Investment
Features
FeesSafety
Academy
More
Pluang+

Compare ASE Technology Holding Co Ltd (ASX) vs Humana Inc (HUM) Price & Performance

ASE Technology Holding Co LtdTrade
Humana IncTrade

Price performance (Past 24H)

Key statistics

ASE Technology Holding Co Ltd vs Humana Inc — how do they compare? ASE Technology Holding Co Ltd trades at $39.59 (market cap $85.75B), while Humana Inc trades at $385.22 (market cap $44.77B). The key difference: ASE Technology Holding Co Ltd is the larger of the two by market cap, and ASE Technology Holding Co Ltd pays the higher dividend (1.08%). Which is the better fit depends on your goals.

ASXHUM
Market Cap
$85.75B$44.77B
Sector
TechnologyHealth
52-Week High
$45.12$409.42
52-Week Low
$9.63$163.67
Enterprise Value
$90.15B$52.12B
Dividend Yield
1.08%0.95%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

ASE Technology Holding Co Ltd

ASE Technology Holding (ASX) trades at $39.62, up 5.39% today, with strong technical momentum and bullish moving averages. The company reported three consecutive quarterly earnings beats, with Q2 2026 EPS of $0.29 exceeding expectations by 26%. Revenue growth accelerated to $645.39B in 2025, with net income reaching $40.02B. Recent news highlights $10.5B capital expenditure increase for AI semiconductor capacity expansion.

Outlook remains positive with 80% analyst buy ratings and projected 2026 revenue of $711.2B. Key opportunities include AI-driven demand growth and margin expansion, while risks involve high valuation multiples (P/E 47.78) and significant capital expenditure commitments. The stock shows strong institutional interest despite some position adjustments by major funds.

Humana Inc

Humana (HUM) trades at $386.11, up 0.17% today, with a neutral technical outlook and mixed fundamentals. The stock shows strong revenue growth reaching $129.66B in 2025 but faces margin compression with net income margin declining to 0.88%. Recent Q2 2026 earnings beat expectations with EPS of $7.61 versus $7.27 expected, while management focuses on Medicare Advantage margin expansion and cost reductions.

Outlook remains cautiously optimistic with a consensus price target of $409.93 offering 6% upside potential. Key opportunities include Medicare Advantage growth and operational efficiency gains, while risks involve margin pressure, regulatory changes in healthcare, and competitive threats. Analyst sentiment leans neutral with 57% hold ratings amid ongoing business transformation.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About ASE Technology Holding Co Ltd

ASE Technology Holding Co Ltd is a semiconductor assembly and testing firm. The company operates in segments: Packaging, Testing, and Electronic Manufacturing Services. Of these, packaging services contribute the most revenue. It involves packaging bare semiconductors into completed semiconductors with improved electrical and thermal characteristics. The Testing Segment includes front-end engineering testing, wafer probing, and final testing services. In the EMS segment, the company designs manufacture and sells electronic components and telecommunication equipment motherboards. The company is based in Taiwan but garners over half its sales from firms in the United States.

Read more on ASX

About Humana Inc

Humana is one of the largest private health insurers in the U.S. with a focus on administering Medicare Advantage plans. The firm has built a niche specializing in government-sponsored programs, with nearly all its medical membership stemming from individual and group Medicare Advantage, Medicaid, and the military's Tricare program. The firm is also a leader in stand-alone prescription drug plans for seniors enrolled in traditional fee-for-service Medicare. Humana offers employer-based plans primarily for small businesses along with specialty insurance offerings such as dental, vision, and life. Beyond medical insurance, the company provides other healthcare services, including primary-care services, at-home services, and pharmacy benefit management.

Read more on HUM